Govt Job: For M.Pharm, M.Sc to work at Indian Institute of Technology

Banaras Hindu University ranks among the first few in the country in the field of academic and research output.

This university has two campuses, 3 institutes, 16 faculties, 140 departments, 4 advanced centers and 4 interdisciplinary schools.

The University is making its mark at the national and international levels in a number of frontier areas of Science, Social Science, Technology, Medicine and Agriculture etc.

Applications are invited from Indian nationals for the post of Senior Research Fellow (SRF) to work on Indian Council of Medical Research (ICMR) sponsored project entitled “Development of novel near infrared fluorescence imaging probes for detecting amyloid beta species in eyes of Alzheimer’s disease animal model” (2019-3088) for a period of approximate three and half months (Till September 14, 2022). The post is purely temporary and co-terminus with the project.

Essential qualifications: First class in MSc. (Life sciences/ biotechnology/ biochemistry/ anatomy/ physiology/ microbiology) with 55% marks (equivalent grade) in post-Graduation with CSIR-UGC, NET including lectureship, or GATE qualified plus at least two years of research experience. Or M.Pharm/M.S.(Pharm.)/M.Tech(Pharm)/M.Tech. in Pharmacology/Medicinal Chemistry/Pharmaceutical Chemistry/Pharmaceutics in post-Graduation with CSIR-UGC, NET including lectureship, or GATE qualified.

Desirable qualifications : Candidates with expertise in animal handling will be preferred. In addition, the cell culture handling experience will be considered.

Salary : As per ICMR norms
Age limit : 32 Years (relaxable for 5 years for SC/ST/Physically Handicapped/Female candidates). All things being equal, SC/ST candidates will be preferred as per GOI rules

Interested candidates are requested to send their applications on a plain paper giving detail information on education qualification, research experience, and publications if any via email via email to Principal Investigator Dr. Gyan Prakash Modi at gpmodi.phe@itbhu.ac.in. Please write “Application for SRF” in the subject line of the email. The shortlisted candidates will be intimated by email

No TA/DA will be paid if called for interview.

General Instructions :
1. The PI has the discretion to restrict the number of candidates to be called for interview to a reasonable limit on the basis of qualifications and experience higher than the minimum prescribed in the advertisement.

2. Only shortlisted candidates will be communicated to appear in the interview and no other communications in this regard will be entertained.

3. Original certificates and self-attested copies of all certificates need to be presented before the interview for verification.

4. Venue of Interview: Department of Pharmaceutical Engineering & Technology, IIT (BHU), Varanasi- 221005. Contact no: +91-7310008444, E-mail: gpmodi.phe@itbhu.ac.in

5. Last date for receiving completed application is Sunday May, 29, 2022.

Related Posts

WHO launches new primary health care course to strengthen health systems globally

Health is a human right – yet not everyone can access the health services they need, when and where they need them, without financial hardship. Primary health care (PHC) provides…

Ayurveda needs stronger evidence, safety monitoring for market adoption, says CCRAS

Bengaluru: The Central Council for Research in Ayurvedic Sciences (CCRAS) has called for stronger scientific evidence, safety monitoring and translation of research into market-ready technologies to improve the credibility and…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

WHO launches new primary health care course to strengthen health systems globally

WHO launches new primary health care course to strengthen health systems globally

Ayurveda needs stronger evidence, safety monitoring for market adoption, says CCRAS

Ayurveda needs stronger evidence, safety monitoring for market adoption, says CCRAS

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert